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Abstract
We evaluated associations of race, primary payer at diagnosis, and survival among patients diagnosed in Florida with 
lung cancer (n = 148,140) and breast cancer (n = 111,795), from 1996 through 2007. In multivariate models adjusted 
for comorbidities, tumor characteristics, and treatment factors, breast cancer survival was worse for Native American 
women than for white women (hazard ratio [HR], 1.52; 95% confidence interval [CI], 1.05–2.20) and for women using 
the Indian Health Service than for women using private insurance (HR, 1.71; 95% CI, 1.33–2.19). No survival 
association was found for Native American compared with white lung cancer patients or those using the Indian Health 
Service versus private insurance in fully adjusted models. Additional resources are needed to improve surveillance 
strategies and to reduce cancer burden in these populations.
Objective
The Indian Health Service (IHS) relationship was initially established in 1787 but formally recognized in 1955 as the 
principal federal health care provider and health advocate for Native Americans (1,2); the goal of IHS health services is 
to optimize the health status of Native Americans. However, long-standing health disparities between Native 
Americans and the general US population exist (1). For example, the life expectancy of Native Americans is shorter 
than that of whites (71.5 y vs 75.6 y) (1). Conversely, mortality rates per 100,000 are lower in Native Americans than in 
the general population for cancers of the lung (43.0 vs 66.7) and breast (9.8 vs 17.7) (3). However, limited research has 
documented associations among Native American race, use of IHS, and survival time after cancer diagnosis (4). In this 
study, we used the Florida Cancer Data System (FCDS), a Florida population-based cancer registry, to examine breast 
and lung cancer survival by Native American race and IHS use for the Seminole and the Miccosukee tribes, the 2 
federally recognized tribes in Florida.
Methods
FCDS data (1996–2007) were linked with data from the Florida Agency for Health Care Administration (AHCA). 
Incident lung cancer and female breast cancer were identified from the FCDS. FCDS collects information on diagnosis, 
stage, demographics, treatments, primary payer at diagnosis, and date of death (5). Patients were categorized as IHS 
users for primary payer at diagnosis if they reported using IHS services in FCDS. AHCA data contain medical records 
on all patients treated at hospitals and free-standing surgical and radiological treatment centers (6).
The primary outcome of our study, overall survival, was elapsed time from diagnosis to date of death or last patient 
encounter. Our main predictors of interest were race (white, Native American, black, Asian, Pacific Islander, Asian 
Indian/Pakistani, or other) and primary payer at diagnosis (private, IHS, Medicaid, Medicare, 
defense/military/veteran, insurance not otherwise specified, or uninsured). However, we focused primarily on Native 
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Americans versus whites and IHS versus private insurance. We excluded non-Florida residents aged 18 years or 
younger, patients with missing values for survival time, and patients with carcinoma in situ.
We used Cox proportional hazards regression models to obtain hazard ratios (HRs) and 95% confidence intervals (CIs) 
by cancer type from 4 models (univariate, multivariate not adjusted for race, not adjusted for IHS, and fully adjusted). 
This project was approved by the University of Miami’s institutional review board.
Results
Of 238, 427 patients who met our study criteria, 41 lung cancer patients and 38 breast cancer patients self-reported as 
Native American; however, 176 lung cancer patients and 177 breast cancer patients reported using IHS providers 
(Table 1). Native Americans with breast and lung cancer were younger than their white counterparts; we found more 
than a 6-year difference in mean age among women with breast cancer (Native Americans, 57.5 y vs whites, 64.1 y). 
Patients using IHS were younger than those using private insurance; we found larger differences among lung cancer 
patients (58.7 y, IHS vs 64.0 y, private insurance) (Table 2).
For female breast cancer patients, Native American race was not significant in the univariate model (HR, 1.38; 95% CI, 
0.93–2.06) (Table 3). But in multivariate models, Native Americans (not adjusted for primary payer) had worse 
survival than whites (HR, 1.48; 95% CI, 1.03–2.12); in the fully adjusted model, Native Americans maintained worse 
survival than whites (HR, 1.52; 95% CI, 1.05–2.20). Breast cancer patients using IHS had worse survival than those 
using private insurance in the univariate model (HR, 1.73; 95% CI, 1.43–2.11) and in the multivariate model without 
adjustment for race (HR, 1.76; 95% CI, 1.36–2.27); this survival disadvantage was maintained in the fully adjusted 
model (HR, 1.71; 95% CI, 1.33–2.19).
In the univariate model, lung cancer patients using IHS had worse survival than those using private insurance (HR, 
1.25; 95% CI, 1.08–1.44), but Native Americans patients did not have worse survival than whites (HR, 1.08; 95% CI, 
0.76–1.53). We found no significant survival differences between Native Americans and whites or IHS use and private 
insurance in any adjusted models.
Discussion
Our study found that Native American race and use of IHS were independent predictors of survival among women 
diagnosed with breast cancer but not for people diagnosed with lung cancer. We also documented little association 
between Native American race and use of IHS; for example, only 3 Native Americans reported receiving health care 
from IHS. This apparent discrepancy possibly arises from people self-reporting race as non-Native American when 
they are of mixed Native American and other race. Incorrect or incomplete classification of Native American race has 
been documented in other health surveillance systems and needs to be addressed to characterize the diverse Native 
American population more accurately in cancer registries (7). Conversely, some research has found high levels of 
agreement between self-reported Native American race and administrative data (8). Researchers cannot assume that 
race is accurately reported. Given documented social and economic disadvantages as well as diverse cultural practices 
among members of the Native American community, our findings, like those of others, raise the question of whether 
current cancer care is adequate to meet the needs of this community (3). For example, some cancer care costs such as 
specialized imaging studies may not be provided by IHS, in part because of chronic program underfunding by 
appropriations from Congress (9).
Although our study controls for numerous factors, it cannot identify small differences in quality of cancer care. Racial 
discrimination and its role in receipt of high-quality cancer care may be a factor in reduced survival, given evidence of 
its adverse influence on cancer screening behaviors in Native American communities (10). Other factors that may 
affect survival for Native Americans with lung and female breast cancer include mistrust of the medical community, 
patient–provider miscommunication, and access to care.
A limitation of our study is that it may not reflect the mortality among Native American groups residing outside of 
Florida. For example, breast cancer mortality rates range from 7.4 to 11.6 per 100,000 across IHS regions (11). 
Although promising work using patient navigators to improve cancer prevention, early detection, and cancer treatment 
outcomes is underway (12), financial support for such activities is limited relative to unmet needs of this population. 
Our study supports calls for additional resources to improve surveillance strategies and reduce cancer burden in this 
population (12,13).
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Tables
Table 1. Sociodemographic Characteristics of White and Native American 
Breast and Lung Cancer Patients (N = 238,427), Florida, 1996–2007
Characteristic
Breast Cancer Lung Cancer
Native American (n 
= 38)
White (n = 
101,517)
Native American (n 
= 41)
White (n = 
136,831)
Mean age, y (SD) 57.5 (13.0) 64.1 (13.9) 67.1 (11.8) 69.9 (10.9)
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Characteristic
Breast Cancer Lung Cancer
Native American (n 
= 38)
White (n = 
101,517)
Native American (n 
= 41)
White (n = 
136,831)
Sex
Male NA NA 29 74,915
Female 38 101,517 12 61,916
Race
White — 101,517 — 136,831
Native American 38 — 41 —
Primary payer at diagnosis
Indian Health Service 3 174 0 176
Private insurance 14 35,664 8 28,547
Medicaid 2 2,560 2 4,585
Medicare 15 46,928 23 86,654
Defense/military/veteran 0 1,236 0 2,300
Insurance not otherwise 
specified
3 11,913 5 9,980
Uninsured 1 3,042 3 4,589
Marital status
Never married 3 9,539 4 13,060
Divorced/separated/widowed 14 32,146 7 41,622
Married 19 57,251 24 78,870
Unknown 2 2,581 6 3,279
Socioeconomic status
Low 10 8,058 7 12,973
Middle low 16 29,433 14 44,485
Middle high 7 40,665 15 54,161
High 5 23,361 5 25,212
Tobacco use
Never smoked 19 49,175 4 11,798
History of smoking 5 20,052 17 59,987
Current smoker 8 13,339 15 49,185
Unknown 6 18,951 5 15,861
Urban/rural
Urban 32 96,092 36 127,301
Rural 6 5,425 5 9,530
Hospital volume
Low 19 60,571 30 93,726
High 19 40,946 11 43,105
Type of health care facility
Nonteaching 28 91,911 39 126,862
a
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Characteristic
Breast Cancer Lung Cancer
Native American (n 
= 38)
White (n = 
101,517)
Native American (n 
= 41)
White (n = 
136,831)
Teaching 10 9,606 2 9,969
Neighborhood area poverty levels derived from the US Census and characterized into 4 groups by percentage of a 
neighborhood living in poverty.
Table 2. Sociodemographic Characteristics of Breast and Lung Cancer 
Patients by Primary Payer at Diagnosis, Florida, 1996–2007
Characteristic
Breast Cancer Lung Cancer
Indian Health Service 
(n = 177)
Private ( n = 
35,678)
Indian Health Service 
(n = 176)
Private (n = 
28,555)
Mean age, y (SD) 52.2 (10.2) 55.9 (12.0) 58.7 (11.2) 64.0 (11.2)
Sex
Male — — 89 15,284
Female 177 35,678 87 13,271
Race
White 174 35,664 176 28,547
Native American 3 14 0 8
Marital status
Never married 46 3,993 44 2,995
Divorced/separated/widowed 59 7,851 73 6,820
Married 66 23,024 56 18,143
Unknown 6 810 3 597
Socioeconomic status
Low 33 2,355 31 2,414
Middle low 69 9,658 62 9,207
Middle high 51 14,248 54 11,489
High 24 9,417 29 5,445
Tobacco use
Never smoked 65 17,148 7 2,339
History of smoking 26 6,452 50 11,080
Current smoker 47 5,357 106 11,778
Unknown 39 6,721 13 3,358
Urban/rural
Urban 175 34,624 171 27,697
Rural 2 1,054 5 858
Hospital volume
Low 54 19,649 96 19,037
High 123 16,029 80 9,518
Type of health care facility
a
a
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Characteristic
Breast Cancer Lung Cancer
Indian Health Service 
(n = 177)
Private ( n = 
35,678)
Indian Health Service 
(n = 176)
Private (n = 
28,555)
Nonteaching 147 31,999 167 26,346
Teaching 30 3,679 9 2,209
Neighborhood area poverty levels derived from the US Census and characterized into 4 groups by percentage of a 
neighborhood living in poverty.
Table 3. Association of Cancer Survival With Native American Race and Use 
of Indian Health Service as Primary Payer , Florida, 1996–2007
Model Factor
       Breast Cancer, Hazard 
Ratio (95% CI)





       1.38 (0.93–2.06)        1.08 (0.76–1.53)
IHS vs private        1.73 (1.43–2.11)        1.25 (1.08–1.44)
Multivariate




       1.48 (1.03–2.12)        0.98 (0.71–1.37)




       1.52 (1.05–2.20)        0.98 (0.71–1.36)
IHS vs private        1.71 (1.33–2.19)        1.21 (0.99–1.49)
Abbreviations: CI, confidence interval; IHS, Indian Health Service.
Other race designations (black, Asian, Pacific Islander, Asian Indian or Pakistani, and other) and other types of primary 
payers at diagnosis (Medicaid, Medicare, defense/ military/veteran, insurance not otherwise specified, and uninsured) were 
included in the model but not shown here. Fully adjusted models included age; other races; other types of primary payers 
at diagnosis; ethnicity (Hispanic or non-Hispanic); sex (for lung cancer); neighborhood area poverty levels derived from the 
US Census and characterized into 4 groups by percentage of neighborhood living in poverty, marital status, smoking status, 
comorbidities; and cancer-related indicators (tumor grade and stage, lymph node status, type of treatments, histology).
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